XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (9,424) $ (15,834) $ (222,300)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 2,645 2,679  
Provision for doubtful accounts 251 26  
Share-based compensation 2,395 5,029  
Amortization of deferred financing costs 113 50  
Interest expense related to debt discount accretion and conversion feature 1,466 72  
Shares issued for services 0 1,038  
Warrants Issued For Settlement Agreement 653 0  
Loss on extinguishment of debt 0 1,000  
Gain on settlement of rental agreement (469) (525)  
Changes in operating assets and liabilities:      
Accounts receivable, net 421 (604)  
Prepaid expenses and other current assets 2,553 603  
Accounts payable and customer deposits (920) 3,537  
Net billings in excess of revenues (193) (117)  
Accrued expenses and other payables (2,537) (1,671)  
Net cash used in operating activities (3,046) (4,717)  
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property, equipment, and software development (1,898) (1,418)  
Acquisition of iPass, net of cash acquired 0 860  
Investment in notes receivable 0 (2,700)  
Net cash used in investing activities (1,898) (3,258)  
CASH FLOWS FROM FINANCING ACTIVITIES:      
Exercise of warrants and options 0 750  
Repayment of loans (239) (10,989)  
Proceeds from issuance of Senior Secured Debt 0 24,024  
Financing-related fees (223) (867)  
Proceeds from issuance of redeemable convertible preferred stock 4,194 0  
Net cash provided by financing activities 3,732 12,918  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (69) (21)  
Increase (decrease) in cash, cash equivalents and restricted cash (1,281) 4,922  
Cash, cash equivalents and restricted cash, beginning of period 5,902 6,482 6,482
Cash, cash equivalents and restricted cash, end of period $ 4,621 $ 11,404 $ 5,902